Imaging findings in acute pediatric coronavirus disease 2019 (COVID-19) pneumonia and multisystem inflammatory syndrome in children (MIS-C)

Pediatr Radiol. 2022 Sep;52(10):1985-1997. doi: 10.1007/s00247-022-05393-9. Epub 2022 May 26.

Abstract

The two primary manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children are acute coronavirus disease 2019 (COVID-19) pneumonia and multisystem inflammatory syndrome (MIS-C). While most pediatric cases of acute COVID-19 disease are mild or asymptomatic, some children are at risk for developing severe pneumonia. In MIS-C, children present a few weeks after SARS-CoV-2 exposure with a febrile illness that can rapidly progress to shock and multiorgan dysfunction. In both diseases, the clinical and laboratory findings can be nonspecific and present a diagnostic challenge. Thoracic imaging is commonly obtained to assist with initial workup, assessment of disease progression, and guidance of therapy. This paper reviews the radiologic findings of acute COVID-19 pneumonia and MIS-C, highlights the key distinctions between the entities, and summarizes our understanding of the role of imaging in managing SARS-CoV-2-related illness in children.

Keywords: Chest; Children; Computed tomography; Coronavirus disease 2019; Lungs; Multisystem inflammatory syndrome in children; Radiography.

Publication types

  • Review

MeSH terms

  • COVID-19* / complications
  • Child
  • Humans
  • SARS-CoV-2
  • Systemic Inflammatory Response Syndrome / diagnostic imaging

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related